JP2022538286A5 - - Google Patents
Info
- Publication number
- JP2022538286A5 JP2022538286A5 JP2021577316A JP2021577316A JP2022538286A5 JP 2022538286 A5 JP2022538286 A5 JP 2022538286A5 JP 2021577316 A JP2021577316 A JP 2021577316A JP 2021577316 A JP2021577316 A JP 2021577316A JP 2022538286 A5 JP2022538286 A5 JP 2022538286A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic composition
- composition according
- compound
- acid
- lmtx
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1909506.6A GB201909506D0 (en) | 2019-07-02 | 2019-07-02 | Synaptopathies |
| GB1909506.6 | 2019-07-02 | ||
| PCT/EP2020/068306 WO2021001326A1 (en) | 2019-07-02 | 2020-06-29 | Methylthioninium for use in the treatment of synaptopathies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022538286A JP2022538286A (ja) | 2022-09-01 |
| JP2022538286A5 true JP2022538286A5 (enExample) | 2023-07-07 |
| JP7610537B2 JP7610537B2 (ja) | 2025-01-08 |
Family
ID=67540130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021577316A Active JP7610537B2 (ja) | 2019-07-02 | 2020-06-29 | シナプス変性症の処置における使用のためのメチルチオニニウム |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220370470A1 (enExample) |
| EP (1) | EP3993805A1 (enExample) |
| JP (1) | JP7610537B2 (enExample) |
| KR (1) | KR20220029711A (enExample) |
| CN (1) | CN114080224A (enExample) |
| AU (1) | AU2020300792B2 (enExample) |
| BR (1) | BR112021025383A2 (enExample) |
| CA (1) | CA3143787A1 (enExample) |
| GB (1) | GB201909506D0 (enExample) |
| IL (1) | IL289371A (enExample) |
| MX (1) | MX2021015288A (enExample) |
| WO (1) | WO2021001326A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY162313A (en) | 2006-07-11 | 2017-05-31 | Wista Lab Ltd | Methods of synthesis and/or purification of diaminophenothiazinium compounds |
| BR112021000802A2 (pt) | 2018-07-26 | 2021-04-13 | Wista Laboratories Ltd. | Dosagem otimizada de diaminofenotiazinas em populações |
| TW202204625A (zh) * | 2020-04-14 | 2022-02-01 | 美商佛羅里達大學研究基金會公司 | 多發性硬化之基因免疫治療與免疫抑制劑之增強功效 |
| US12410394B2 (en) | 2023-01-06 | 2025-09-09 | Athergen, Inc. | Composition comprising nicotinamide mononucleotide and leucomethylene blue |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020040032A1 (en) | 2000-07-07 | 2002-04-04 | Glasky Michelle S. | Methods for stimulation of synthesis of synaptophysin in the central nervous system |
| GB0100119D0 (en) | 2001-01-03 | 2001-02-14 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
| CN104119294B (zh) | 2006-03-29 | 2018-10-30 | 维斯塔实验室有限公司 | 3,7-二氨基-10h-吩噻嗪化合物的制备方法 |
| AU2008265045B2 (en) | 2007-06-19 | 2014-02-27 | Taurx Therapeutics Management Ltd. | Phenothiazine compounds for treating Mild Cognitive Impairment |
| PT2954932T (pt) | 2007-10-03 | 2018-12-12 | Wista Lab Ltd | Utilização terapêutica de diaminofenotiazinas |
| KR101888713B1 (ko) | 2011-02-11 | 2018-08-14 | 위스타 레보레이토리스 리미티드 | 페노티아진 디아미늄 염 및 이의 용도 |
| PL3487505T3 (pl) | 2016-07-25 | 2023-10-09 | Wista Laboratories Ltd. | Podawanie i dawkowanie diaminofenotiazyn |
| GB201614834D0 (en) | 2016-09-01 | 2016-10-19 | Wista Lab Ltd | Treatment of dementia |
| JP6756661B2 (ja) | 2017-04-28 | 2020-09-16 | 日立オートモティブシステムズ株式会社 | 車両電子制御装置 |
-
2019
- 2019-07-02 GB GBGB1909506.6A patent/GB201909506D0/en not_active Ceased
-
2020
- 2020-06-29 MX MX2021015288A patent/MX2021015288A/es unknown
- 2020-06-29 WO PCT/EP2020/068306 patent/WO2021001326A1/en not_active Ceased
- 2020-06-29 CN CN202080048560.8A patent/CN114080224A/zh active Pending
- 2020-06-29 KR KR1020227003215A patent/KR20220029711A/ko not_active Ceased
- 2020-06-29 EP EP20737381.2A patent/EP3993805A1/en active Pending
- 2020-06-29 BR BR112021025383A patent/BR112021025383A2/pt not_active Application Discontinuation
- 2020-06-29 US US17/620,966 patent/US20220370470A1/en not_active Abandoned
- 2020-06-29 CA CA3143787A patent/CA3143787A1/en active Pending
- 2020-06-29 AU AU2020300792A patent/AU2020300792B2/en active Active
- 2020-06-29 JP JP2021577316A patent/JP7610537B2/ja active Active
-
2021
- 2021-12-26 IL IL289371A patent/IL289371A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2323696B1 (en) | Optical method for the detection of alzheimer's disease | |
| JP2015510941A5 (enExample) | ||
| JP2024516371A5 (enExample) | ||
| JP2018035197A5 (enExample) | ||
| JP2019516739A5 (enExample) | ||
| JP2022515293A5 (enExample) | ||
| JP2019532029A5 (enExample) | ||
| JP2009510044A5 (enExample) | ||
| JP2019524822A5 (enExample) | ||
| JP2017075173A5 (enExample) | ||
| JP2015508092A5 (enExample) | ||
| JP2019529541A5 (enExample) | ||
| JP2019529514A5 (enExample) | ||
| JP2013544786A5 (enExample) | ||
| JP2024531437A5 (enExample) | ||
| JP2017521364A5 (enExample) | ||
| JP2019515040A5 (enExample) | ||
| JP2023011735A5 (enExample) | ||
| JP2022065024A5 (enExample) | ||
| JP2022552520A5 (enExample) | ||
| JP2009526834A5 (enExample) | ||
| US20150272941A1 (en) | Medicinal treatment of chronic pulmonary inflammatory diseases with norketotifen | |
| CA2886194C (en) | Medicinal treatment of chronic dermal inflammatory diseases with norketotifen | |
| JP2008540528A5 (enExample) | ||
| JP2023511152A5 (enExample) |